(Q39465331)

12 September 2017

A pilot study of intravenous ondansetron for hyperemesis gravidarum (English)

1 reference

12 September 2017

C A Sullivan

1

1 reference

12 September 2017

C A Johnson

2

1 reference

12 September 2017

H Roach

3

1 reference

12 September 2017

R W Martin

4

1 reference

12 September 2017

D K Stewart

5

1 reference

12 September 2017

J C Morrison

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Obstetrics and Gynecology

12 September 2017

1 reference

12 September 2017

174

1 reference

12 September 2017

5

1 reference

12 September 2017

1565-1568

1 reference

Relationships between ondansetron systemic exposure and antiemetic efficacy and safety in cancer patients receiving cisplatin

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

Ondansetron and hyperemesis gravidarum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

Ondansetron and hyperemesis gravidarum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

7 January 2021

Measurement of nausea

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

Nausea and vomiting in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970607-5

10.1016/S0002-9378(96)70607-5

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference